NCT01704846 - Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Hepatitis C

Interventions

DRUG

BI 201335 NA 120 mg capsule

1capsule of BI 201335 NA 120 mg capsule

DRUG

BI 201335 NA 120 mg capsule

1 capsule of BI 201335 NA 120 mg capsule

DRUG

BI 201335 NA 40 mg capsule

3 capsules of BI 201335 NA 40 mg capsule

DRUG

BI 201335 NA 40 mg capsule

3 capsules of BI 201335 NA 40 mg capsule

Trial Locations (1)

1220.53.08101 Boehringer Ingelheim Investigational Site, Sumida-ku,Tokyo